Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced the launch of a dedicated sales ...

Of the compounds Nick sent me for testing, I identified CGP 57148B (also known as STI571, Gleevec, Glivec or imatinib mesylate) as the most effective at killing CML cells without harming normal ...

The lawsuit alleges that JPMorgan breached its fiduciary duties under the Employee Retirement Income Security Act, the law that governs large employers’ benefit plans. The plaintiffs argue that ...

Tenax Therapeutics (NASDAQ:TENX – Get Free Report)‘s stock had its “outperform” rating restated by research analysts at William Blair in a report released on Monday,RTT News reports. Separately, ...

A new study highlights the role of inflammatory biomarkers, mitotic index, and imatinib adherence in predicting survival outcomes in high-risk gastrointestinal stromal tumours.

Black women with chronic myeloid leukemia face unique challenges when it comes to diagnosis, treatment, and overall disease ...

Discontinuing tyrosine kinase inhibitor maintenance after extended complete molecular response should only be attempted as part of a clinical trial, the researchers say.

Zydus Lifesciences added 3.33% to Rs 917.10 after the company said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture generic Dasatinib ...

Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax Therapeutics” or the “Company”), a Phase 3, development-stage pharmaceutical company focused on identifying, developing and commercializing products ...

Cost Plus Drugs inked deals with MultiCare Health System, Network Health, Blue Cross and Blue Shield insurers and others ...

Gleevec response in GIST varies by mutational profile, with KIT-exon-11 mutation linked to better outcomes, emphasizing ...

Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration to manufacture ...